DSM-Firmenich stock gets a EUR 540 million buyback boost

Published on 10/04/2026 at 22:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

DSM-Firmenich stock reflects a completed EUR 540 million buyback announced on October 1, 2026. The planned cancellation covers 6,488,446 shares and changes the capital base.

Pop-Art-Comic mit Wissenschaftler und bunten Duftstoff-Fläschchen im Labor — dsm-firmenich AG (ISIN CH1216478797) wird als farbenfrohe Pop-Art-Comic-Szene mit Wissenschaftler und bunten Duftfläschchen inszeniert, Illustration mit AI erstellt.

DSM-Firmenich stock was last quoted at CHF 93.05 on SIX on September 30, 2026, after the company completed its EUR 540 million share repurchase program on October 1, 2026. The planned cancellation of 6,488,446 shares gives the capital measure a concrete next step.

Buyback reaches its final stage

According to dsm-firmenich on October 1, 2026, the group repurchased 7,169,147 shares at an average price of EUR 75.32. The program included EUR 40 million for share-based compensation commitments and EUR 500 million for issued-capital reduction.

The company plans to cancel 6,488,446 shares by the end of the first quarter of 2027. Issued shares would then fall from 253,626,947 to 247,138,501, a direct reduction in the number of shares represented by the company.

Second quarter set the operating base

DSM-Firmenich reported EUR 4.664 billion of revenue and EUR 887 million of EBITDA for Q2/2026 in figures cited by De Belegger. The same report put adjusted EBITDA at EUR 900 million for the first half and the adjusted EBITDA margin at 19.3 percent.

That comparison matters because Q2 adjusted EBITDA margin reached 19.5 percent, while first-half comparable revenue growth stood at 5 percent and Q2 comparable growth at 6 percent. The figures link the buyback story to the operating performance rather than treating the capital action in isolation.

Consensus remains above the quote

MarketScreener listed an Outperform consensus from 20 analysts on September 23, 2026. The average target was EUR 93.62, with a high target of EUR 117.00 and a low target of EUR 67.00.

BNP Paribas analyst Nicola Tang cut DSM-Firmenich from Outperform to Neutral with a EUR 100 target on October 2, 2026, according to Markets Insider. The contrast between a positive aggregate view and a fresh individual downgrade makes execution and cash conversion central to the next assessment.

DSM-Firmenich stock stays tied to capital discipline

At CHF 93.05 on September 30, 2026, DSM-Firmenich had a market capitalization of CHF 23.4 billion. The SIX quotation was up 0.11 percent on that session, giving the completed buyback a neutral market backdrop rather than a sharp price reaction.